In a report out Tuesday, hospital groups said drug prices have skyrocketed since 2013, triggering a huge increase in what hospitals spend on pharmaceuticals.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
Four years after a huge push to speed generics to market, the FDA has more than 4,000 generics waiting for approval.
Researchers at Harvard University examined thousands of studies to determine why drug prices have climbed and what might be done about it.
Some experts said the findings stemming from this systematic review of existing studies was reassuring, but not surprising.